Article Information
History
- January 16, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sharifa Nasreen1,2,
- Andrew Calzavara2,
- Sarah A. Buchan1,2,3,
- Nisha Thampi3,4,
- Caitlin Johnson3,
- Sarah E. Wilson1,2,3,
- Jeffrey C. Kwong1,2,3,5,6,* and
- on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Ontario investigators
- 1Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
- 2ICES, Toronto, ON, Canada
- 3Public Health Ontario, ON, Canada
- 4Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
- 5Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada
- 6University Health Network, Toronto, ON, Canada
- ↵*Corresponding author: Jeffrey C. Kwong, Senior Scientist, ICES, G1 06, 2075 Bayview Avenue, Toronto, Ontario, Canada, M4N 3M5, jeff.kwong{at}utoronto.ca, Phone: (416) 480-4055 x1-7665 Fax: (416) 480-6048
Posted January 16, 2022.
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
